Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

The Biggest News of 2023: TCTMD’s Top 10

News Opinion Editor's Corner

The Biggest News of 2023: TCTMD’s Top 10

January 01, 2024

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Presentation TCT 2022

2bIIIA Inhibitors and Bleeding Risk When Complications Develop: Risks vs. Benefits of Anticoagulation Agents

Presenter: Craig Beavers

September 16, 2022

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

August 11, 2022

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

News Features

Subtherapeutic Heparin: As Stories Multiply, Concerns Mount

Yael L. Maxwell

November 27, 2019

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

News Conference News ACC 2018

SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients

Michael O'Riordan

March 11, 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

News Conference News ACC 2018

TREAT: No Major Bleeds With Ticagrelor in ACS Patients After Fibrinolysis

March 11, 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

News Conference News ACC 2018

Reducing Co-payments for P2Y12 Inhibitors Upped Ticagrelor Use but Didn’t Budge MACE: ARTEMIS

March 11, 2018

News Daily News

AHA Advises Physicians to Monitor Medications That Might Cause or Worsen Heart Failure

Michael H. Wilson

July 12, 2016

News Daily News

Pharmacists Can Take an Active Role in Lowering CV Risk Factors, Likelihood of Events

Michael H. Wilson

June 21, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.